SCHEMBL30830719

SCHEMBL30830719

COC(=O)c1ccc([C@H]2C[C@@H](Nc3ccn(C)c(=O)c3Br)CN(C)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 13/20 0.51
▸ BRD9 Q9H8M2 3/20 0.51
▸ BPTF Q12830 2/20 0.51
▸ BRD1 O95696 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ BRPF1 P55201 1/20 0.51
▸ KAT2A Q92830 1/20 0.51
▸ BRD7 Q9NPI1 1/20 0.51
▸ BAZ2B Q9UIF8 1/20 0.51
▸ BRPF3 Q9ULD4 1/20 0.51
▸ SETDB1 Q15047 2/20 0.42
▸ TSHR P16473 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830681 0.90 KAT2B (0.55) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830993 0.88 KAT2B (0.51) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830795 0.84 KAT2B (0.73) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830560 0.84 KAT2B (0.73) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830565 0.84 KAT2B (0.53) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830783 0.82 KAT2B (0.53) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830678 0.80 SETDB1 (0.41) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830695 0.78 KAT2B (0.55) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830660 0.77 KAT2B (0.46) KAT2BBRD9BPTFBRD1ACHE
SCHEMBL30830923 0.76 KAT2B (0.56) KAT2BBRD9BPTFBRD1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback